UBS analyst Kevin Caliendo reiterated a Buy rating and $97.00 price target on CVS Health (NYSE: CVS).The analyst commmented, "On ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE